Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
1(7%)
Results Posted
38%(3 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_3
2
14%
Ph phase_1
2
14%
Ph phase_4
7
50%
Ph not_applicable
2
14%

Phase Distribution

2

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
2(15.4%)
Phase 3Large-scale testing
2(15.4%)
Phase 4Post-market surveillance
7(53.8%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(8)
Terminated(2)
Other(3)

Detailed Status

Completed8
unknown3
Terminated2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (15.4%)
Phase 32 (15.4%)
Phase 47 (53.8%)
N/A2 (15.4%)

Trials by Status

unknown321%
completed857%
terminated214%
active_not_recruiting17%

Recent Activity

1 active trials
Showing 5 of 14
active_not_recruitingnot_applicable

Ovarian Reserve Testing in Female Young Adult Cancer Survivors

NCT01421095
completednot_applicable

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

NCT02478775
completedphase_4

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

NCT02554279
completedphase_1

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

NCT01477073
terminatedphase_4

Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

NCT03181685
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT01421095Not Applicable

Ovarian Reserve Testing in Female Young Adult Cancer Survivors

Active Not Recruiting
NCT02478775Not Applicable

Dysregulation of FSH in Obesity: Functional and Statistical Analysis

Completed
NCT02554279Phase 4

MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population

Completed
NCT01477073Phase 1

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

Completed
NCT03181685Phase 4

Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI Cycles

Terminated
NCT04008966Phase 4

Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

Completed
NCT01816321Phase 3

Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial

Completed
NCT02719093Phase 4

Role of FSHR Polymorphism p.N680S in the Therapy With FSH in Patients Who Underwent Varicocele Surgery

Unknown
NCT02213627Phase 4

Use of Corifolitropin Alfa in Oocyte Donors

Unknown
NCT02437032Phase 4

Gonadotropin Type in Ovarian Stimulation

Completed
NCT01345812Phase 4

Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.

Terminated
NCT00884221Phase 3

MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer

Completed
NCT00823121Phase 1

Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

Unknown
NCT00809952

Ultrasound Guided Artificial Insemination

Completed

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14